States Regulate PBMs; CVS Sues
Analysis based on 10 articles · First reported Jun 27, 2026 · Last updated Jun 28, 2026
The ongoing regulatory actions by various states and the United States against pharmacy benefit managers like CVS Health create uncertainty for the pharmaceutical and healthcare industries. Increased regulation and potential limitations on PBM operations could impact their profitability and business models, while potentially benefiting independent pharmacies and consumers through lower drug costs and increased transparency.
States across the U.S., including United States — Tennessee, United States — Arkansas, United States — Louisiana, and United States — Kansas, are implementing new laws to regulate pharmacy benefit managers (PBMs) and lower prescription drug costs. These regulations include limiting PBM compensation, setting minimum payments to pharmacists, requiring more disclosure, and in United States — Tennessee's case, barring PBMs from operating retail pharmacies. CVS Health, a major PBM, is actively fighting these regulations through lawsuits and advertising campaigns, having sued United States — Tennessee and United States — Arkansas, and settled with United States — Louisiana for $45 million. Meanwhile, the United States has also passed new PBM regulations, specifically preventing PBMs from retaining rebates on drug prices for health plans supplementing United States — Medicare coverage. This widespread regulatory push aims to address consumer concerns about medication affordability and the perceived negative impact of PBM practices on independent pharmacies.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard